(Q36891898)

16 August 2017

1 reference

title

Appropriate blood pressure control in hypertensive and normotensive type 2 diabetes mellitus: a summary of the ABCD trial (English)

1 reference

16 August 2017

1 reference

Robert William Schrier

series ordinal

1

object named as

Robert W Schrier

1 reference

16 August 2017

4

William R Hiatt

1 reference

16 August 2017

Raymond O Estacio

2

1 reference

16 August 2017

Philip S Mehler

series ordinal

3

1 reference

16 August 2017

publication date

1 August 2007

1 reference

Nature Clinical Practice Nephrology

16 August 2017

published in

1 reference

16 August 2017

volume

3

1 reference

16 August 2017

issue

8

1 reference

16 August 2017

page(s)

428-438

1 reference

Association of hemoglobin A1c with cardiovascular disease and mortality in adults: the European prospective investigation into cancer in Norfolk

16 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0559

Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0559

Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0559

7 January 2021

Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in U.S. adults. The Third National Health and Nutrition Examination Survey, 1988-1994.

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0559

7 January 2021

Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0559

7 January 2021

Standards of medical care in diabetes--2007.

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0559

7 January 2021

Lack of improvement in the treatment of hyperlipidemia among patients with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0559

7 January 2021

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0559

7 January 2021

Baseline characteristics of participants in the Appropriate Blood Pressure Control in Diabetes trial

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0559

7 January 2021

Associations of hypertension and complications in non-insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0559

7 January 2021

Urinary albumin excretion as a predictor of diabetic retinopathy, neuropathy, and cardiovascular disease in NIDDM.

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0559

7 January 2021

Risks for sensorimotor peripheral neuropathy and autonomic neuropathy in non-insulin-dependent diabetes mellitus (NIDDM)

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0559

7 January 2021

Angiotensin-converting enzyme gene polymorphism in non-insulin dependent diabetes mellitus and its relationship with diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0559

7 January 2021

Deletion polymorphism of the angiotensin converting enzyme gene is associated with an increase in left ventricular mass in men with type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0559

7 January 2021

Smoking as a risk factor for nephropathy in non-insulin-dependent diabetics

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0559

7 January 2021

Total homocysteine is associated with nephropathy in non-insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0559

7 January 2021

Increasing homocysteine levels and diabetic autonomic neuropathy

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0559

7 January 2021

The association between diabetic complications and exercise capacity in NIDDM patients

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0559

7 January 2021

Albuminuria as a predictor of heart failure hospitalizations in patients with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0559

7 January 2021

Diabetic autonomic neuropathy is associated with an increased incidence of strokes

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0559

7 January 2021

The effect of nisoldipine as compared with enalapril on cardiovascular outcomes in patients with non-insulin-dependent diabetes and hypertension

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0559

7 January 2021

Differential effects of antihypertensive agents on electrocardiographic voltage: results from the Appropriate Blood Pressure Control in Diabetes (ABCD) trial

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0559

7 January 2021

Cardiac and renal effects of standard versus rigorous blood pressure control in autosomal-dominant polycystic kidney disease: results of a seven-year prospective randomized study

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0559

7 January 2021

Outcome results of the Fosinopril Versus Amlodipine Cardiovascular Events Randomized Trial (FACET) in patients with hypertension and NIDDM.

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0559

7 January 2021

Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the Captopril Prevention Project (CAPPP) randomised trial

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0559

7 January 2021

Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0559

7 January 2021

Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Heart Outcomes Prevention Evaluation Study Investigators

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0559

7 January 2021

Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0559

7 January 2021

Outcomes in hypertensive black and nonblack patients treated with chlorthalidone, amlodipine, and lisinopril.

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0559

7 January 2021

Early aggressive antihypertensive treatment reduces rate of decline in kidney function in diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0559

7 January 2021

Effects of aggressive blood pressure control in normotensive type 2 diabetic patients on albuminuria, retinopathy and strokes

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0559

7 January 2021

Albuminuria and Poor Glycemic Control Predict Mortality in NIDDM

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0559

7 January 2021

Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0559

7 January 2021

Intensive blood pressure control reduces the risk of cardiovascular events in patients with peripheral arterial disease and type 2 diabetes

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0559

7 January 2021

Relationship between urinary albumin excretion and left ventricular mass with mortality in patients with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0559

7 January 2021

Exercise capacity is a predictor of cardiovascular events in patients with type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0559

7 January 2021

Impaired fibrinolytic activity in type II diabetes: correlation with urinary albumin excretion and progression of renal disease

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0559

7 January 2021

Effect of intensive blood pressure control with valsartan on urinary albumin excretion in normotensive patients with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0559

7 January 2021

Identifiers

DOI

10.1038/NCPNEPH0559

1 reference

16 August 2017

1 reference